galactosyl-(1-3)galactose has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenberg, S | 1 |
| Carlson, CB; Dykhuizen, EC; Kiessling, LL; Mowery, P; Owen, RM | 1 |
| Borrebaeck, CK; Malmborg, AC; Ohlin, M | 1 |
| Apostolopoulos, V; McKenzie, IF; Sandrin, MS | 1 |
| Jäger, U; Porter, C; Takeuchi, Y | 1 |
1 review(s) available for galactosyl-(1-3)galactose and Neoplasms
| Article | Year |
|---|---|
Carbohydrate/peptide mimics: effect on MUC1 cancer immunotherapy.
Topics: Animals; Carbohydrates; Cross Reactions; Disaccharides; Humans; Immunotherapy; Mannans; Mice; Molecular Mimicry; Mucin-1; Neoplasms; Peptides | 1999 |
4 other study(ies) available for galactosyl-(1-3)galactose and Neoplasms
| Article | Year |
|---|---|
The case of the regional risk.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bites and Stings; Cetuximab; Cluster Analysis; Disaccharides; Female; Geography; Humans; Immunoglobulin E; Male; Neoplasms; Risk Assessment; Sex Distribution; Smoking; Southeastern United States; Ticks | 2013 |
Selective tumor cell targeting using low-affinity, multivalent interactions.
Topics: Antineoplastic Agents; Cell Line, Tumor; Complement System Proteins; Disaccharides; Doxorubicin; Drug Design; Humans; Integrin alphaVbeta3; Molecular Weight; Neoplasms; Oligopeptides | 2007 |
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
Topics: Animals; Antibodies, Heterophile; Antibodies, Monoclonal; Carbohydrate Sequence; Disaccharides; Glycosylation; Humans; Immunotherapy; Mice; Molecular Sequence Data; Neoplasms | 1993 |
Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer.
Topics: Antigens, Heterophile; Complement System Proteins; Disaccharides; Flow Cytometry; Gene Transfer Techniques; Genetic Therapy; Humans; Neoplasms; Retroviridae; Tumor Cells, Cultured | 1999 |